PTC Therapeutics, Inc. (PTCT) Stock Declines -2.03% This Week; Should You Buy?

PTC Therapeutics, Inc. (PTCT) stock is lower by -37.89% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives PTCT stock a score of 24 out of a possible 100.

That rank is mainly influenced by a short-term technical score of 22. PTCT's rank also includes a long-term technical score of 37.

PTCT has an Overall Score of 24. Find out what this means to you and get the rest of the rankings on PTCT!

See Full PTCT Report

What's Happening with PTCT Stock Today

PTC Therapeutics, Inc. (PTCT) stock is down -2.3% while the S&P 500 is lower by -0.18% as of 12:32 PM on Monday, Mar 25. PTCT is lower by -$0.67 from the previous closing price of $29.09 on volume of 94,146 shares. Over the past year the S&P 500 is up 31.36% while PTCT is lower by -37.89%. PTCT lost -$8.37 per share in the over the last 12 months. Click Here to get the full Stock Report for PTC Therapeutics, Inc. stock.